Claims
- 1. A non-Division 5.1 Oxidizer tablet consisting essentially of a blend of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the blend contains at least about 17% by weight of water based on the total weight of the blend; contains from about 0.1% to about 10% of lime based on the total weight of the hydrated calcium hypochlorate and magnesium sulfate heptahydrate and the average dissolving rate of the tablet is less than 150 grams per day.
- 2. The tablet of claim 1 wherein the composition contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
- 3. The tablet of claim 1 wherein the composition contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
- 4. The tablet of claim 1 wherein the amount of water in the composition is from about 18% to about 24% by weight of the composition.
- 5. The tablet of claim 1 wherein the tablet contains from about 0.5% to about 3% by weight of lime, said percentage based on the combined weight of the hydrated calcium hypochlorite and magnesium sulfate heptahydrate.
- 6. The tablet of claim 1 wherein the tablet contains about 1% to about 2% by weight of lime, said percentage based on the combined weight of the hydrated weight of the hydrated calcium hypochlorite and magnesium sulfate heptahydrate.
- 7. The tablet of claim 1 wherein the average dissolving rate is less than about 100 grams per day.
- 8. A non-Division 5.1 Oxidizer tablet consisting of a blend of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, wherein the blend contains at least 17% by weight of water based on the total weight of the blend; contains from about 0.1 to about 10% of lime based on the total weight of the hydrated calcium hypochlorate and magnesium sulfate heptahydrate and the average dissolving rate of the blend is less than 150 grams per day.
- 9. The tablet of claim 8 wherein the composition contains at least 25% by weight of magnesium sulfate heptahydrate and less than about 75% by weight of hydrated calcium hypochlorite.
- 10. The tablet of claim 9 wherein the composition contains about 25% to about 40% by weight of magnesium sulfate heptahydrate and about 60% to about 75% of hydrated calcium hypochlorite.
- 11. The tablet of claim 10 wherein the amount of water in the composition is about 18% to about 24% by weight of the composition.
- 12. The tablet of claim 11 wherein the average dissolving rate is less than 100 grams per day.
- 13. The tablet of claim 12 wherein the tablet contains from about 0.5% to about 3% by weight of lime, said percentage based on the combined weight of the hydrated calcium hypochlorite and magnesium sulfate heptahydrate.
- 14. The tablet of claim 12 wherein the tablet contains about 1% to about 2% by weight of lime, said percentage based on the combined weight of the hydrated weight of the hydrated calcium hypochlorite and magnesium sulfate heptahydrate.
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application is a continuation of U.S. patent application Ser. No. 10/405,388 entitled “CALCIUM HYPOCHLORITE BLENDED TABLETS” filed on Apr. 2, 2003. That present application is incorporated herein by reference in its entirety.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
10405388 |
Apr 2003 |
US |
Child |
10783210 |
Feb 2004 |
US |